vs
Side-by-side financial comparison of Sunshine Biopharma Inc. (SBFM) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $8.6M, roughly 1.0× Sunshine Biopharma Inc.). On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -29.7%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $-1.6M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -12.5%).
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
SBFM vs SWKH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $8.7M |
| Net Profit | $-2.1M | $-19.4M |
| Gross Margin | 35.3% | — |
| Operating Margin | -20.9% | 9.9% |
| Net Margin | -25.0% | — |
| Revenue YoY | -10.6% | -29.7% |
| Net Profit YoY | 0.8% | -430.2% |
| EPS (diluted) | — | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $8.7M | ||
| Q3 25 | $9.4M | $10.9M | ||
| Q2 25 | $9.4M | $10.1M | ||
| Q1 25 | $8.9M | $11.8M | ||
| Q4 24 | $9.6M | $12.4M | ||
| Q3 24 | $8.4M | $10.4M | ||
| Q2 24 | $9.3M | $10.8M | ||
| Q1 24 | $7.5M | $11.4M |
| Q4 25 | $-2.1M | $-19.4M | ||
| Q3 25 | $-883.8K | $8.8M | ||
| Q2 25 | $-1.8M | $3.5M | ||
| Q1 25 | $-1.2M | $4.5M | ||
| Q4 24 | $-2.2M | $5.9M | ||
| Q3 24 | $-1.2M | $3.5M | ||
| Q2 24 | $-494.3K | $3.7M | ||
| Q1 24 | $-1.3M | $468.0K |
| Q4 25 | 35.3% | — | ||
| Q3 25 | 32.6% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 32.2% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 25.3% | — | ||
| Q1 24 | 31.2% | — |
| Q4 25 | -20.9% | 9.9% | ||
| Q3 25 | -11.5% | 61.3% | ||
| Q2 25 | -21.8% | 46.1% | ||
| Q1 25 | -14.6% | 68.6% | ||
| Q4 24 | -21.7% | 44.7% | ||
| Q3 24 | -13.1% | 39.2% | ||
| Q2 24 | -13.6% | 8.3% | ||
| Q1 24 | -17.9% | 9.5% |
| Q4 25 | -25.0% | — | ||
| Q3 25 | -9.4% | 80.7% | ||
| Q2 25 | -18.8% | 35.2% | ||
| Q1 25 | -13.3% | 38.4% | ||
| Q4 24 | -22.5% | 47.5% | ||
| Q3 24 | -14.2% | 33.3% | ||
| Q2 24 | -5.3% | 33.9% | ||
| Q1 24 | -17.0% | 4.1% |
| Q4 25 | — | $-1.59 | ||
| Q3 25 | $-0.54 | $0.72 | ||
| Q2 25 | $-0.82 | $0.29 | ||
| Q1 25 | $-0.44 | $0.37 | ||
| Q4 24 | $49.77 | $0.47 | ||
| Q3 24 | $-11.61 | $0.28 | ||
| Q2 24 | $-43.48 | $0.30 | ||
| Q1 24 | $-2.00 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $42.8M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $23.0M | $235.1M |
| Total Assets | $30.1M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $29.8M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | — | $17.2M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | $23.0M | $235.1M | ||
| Q3 25 | $24.2M | $254.2M | ||
| Q2 25 | $25.7M | $246.5M | ||
| Q1 25 | $22.7M | $292.7M | ||
| Q4 24 | $23.5M | $288.7M | ||
| Q3 24 | $25.0M | $283.4M | ||
| Q2 24 | $23.5M | $282.8M | ||
| Q1 24 | $24.8M | $279.9M |
| Q4 25 | $30.1M | $272.4M | ||
| Q3 25 | $31.5M | $289.4M | ||
| Q2 25 | $32.0M | $285.7M | ||
| Q1 25 | $29.2M | $331.3M | ||
| Q4 24 | $30.6M | $332.2M | ||
| Q3 24 | $30.1M | $321.3M | ||
| Q2 24 | $29.3M | $321.0M | ||
| Q1 24 | $31.9M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $27.3M |
| Free Cash FlowOCF − Capex | $-1.6M | $26.8M |
| FCF MarginFCF / Revenue | -18.9% | 308.1% |
| Capex IntensityCapex / Revenue | 0.0% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.6M | $27.3M | ||
| Q3 25 | $-727.8K | $906.0K | ||
| Q2 25 | $-1.3M | $7.8M | ||
| Q1 25 | $-1.7M | $8.3M | ||
| Q4 24 | $-3.4M | $23.0M | ||
| Q3 24 | $-1.4M | $6.3M | ||
| Q2 24 | $-4.6M | $5.4M | ||
| Q1 24 | $-3.2M | $4.4M |
| Q4 25 | $-1.6M | $26.8M | ||
| Q3 25 | $-735.8K | $557.0K | ||
| Q2 25 | $-1.4M | $7.7M | ||
| Q1 25 | $-1.7M | $8.2M | ||
| Q4 24 | $-3.5M | $22.9M | ||
| Q3 24 | $-1.9M | $6.3M | ||
| Q2 24 | $-5.6M | $5.4M | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | -18.9% | 308.1% | ||
| Q3 25 | -7.8% | 5.1% | ||
| Q2 25 | -15.2% | 77.0% | ||
| Q1 25 | -19.3% | 69.1% | ||
| Q4 24 | -36.6% | 185.3% | ||
| Q3 24 | -22.2% | 60.4% | ||
| Q2 24 | -59.7% | 49.7% | ||
| Q1 24 | -43.1% | — |
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | 1.7% | 0.6% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 1.1% | 1.1% | ||
| Q3 24 | 6.1% | 0.3% | ||
| Q2 24 | 10.5% | 0.2% | ||
| Q1 24 | 0.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBFM
Segment breakdown not available.
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
